Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Therapeutics Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Apoptosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2017

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Research - peer-reviewArticle

temozolomide
Acute Myeloid Leukemia
Poly(ADP-ribose) Polymerase Inhibitors
veliparib
Methylation

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E. Feb 15 2017 In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Research - peer-reviewArticle

Leukemia, Myelomonocytic, Chronic
Topotecan
Carboplatin
Leukemia
Neoplasms
Graft vs Host Disease
Cyclophosphamide
Transplantation
Recurrence
Bone Marrow

Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature

Norsworthy, K. J., DeZern, A. E., Tsai, H. L., Hand, W. A., Varadhan, R., Gore, S. D., Gojo, I., Pratz, K., Carraway, H. E., Showel, M., McDevitt, M. A., Gladstone, D., Ghiaur, G., Prince, G., Seung, A. H., Benani, D., Levis, M. J., Karp, J. E. & Smith, B. D. Oct 1 2017 In : Leukemia Research. 61, p. 25-32 8 p.

Research output: Research - peer-reviewArticle

Acute Myeloid Leukemia
Retrospective Studies
Therapeutics
Survival
Pharmaceutical Preparations

Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies

Norsworthy, K. J., Cho, E., Arora, J., Kowalski, J., Tsai, H. L., Warlick, E., Showel, M., Pratz, K. W., Sutherland, L. A., Gore, S. D., Ferguson, A., Sakoian, S., Greer, J., Espinoza-Delgado, I., Jones, R. J., Matsui, W. H. & Smith, B. D. Oct 1 2016 In : Leukemia Research. 49, p. 90-97 8 p.

Research output: Research - peer-reviewArticle

Neoplasms
Therapeutics
entinostat
bexarotene
Granulocyte-Macrophage Colony-Stimulating Factor